Notes And Other Explanatory Information [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
|---|---|
| Notes and other explanatory information [abstract] | |
| Disclosure of accounting judgements and estimates [text block] |
1.1.
|
| Disclosure of auditors' remuneration [text block] |
NOTE 16.
|
| Disclosure of authorisation of financial statements [text block] |
Le Conseil d’Administration a arrêté le 9 février 2023 les états financiers consolidés au 31 décembre 2022. Les comptes ne seront définitifs qu’après leur approbation par l’Assemblée Générale des actionnaires qui se tiendra le 21 avril 2023.
|
| Disclosure of business combinations [text block] |
2.1.1.
|
| Disclosure of cash flow statement [text block] |
3.5.
|
| Disclosure of changes in accounting policies, accounting estimates and errors [text block] |
Le Groupe n’a pas anticipé de normes et interprétations dont l’application n’est pas obligatoire en 2022.
|
| Disclosure of collateral [text block] |
9.1.9.
|
| Disclosure of commitments and contingent liabilities [text block] |
9.1.10.
|
| Disclosure of contingent liabilities [text block] |
12.2.
|
| Disclosure of cost of sales [text block] |
Coût des ventes
|
| Disclosure of deferred taxes [text block] |
Principes comptables
|
| Disclosure of derivative financial instruments [text block] |
Principes comptables
|
| Disclosure of earnings per share [text block] |
11.4.
|
| Disclosure of effect of changes in foreign exchange rates [text block] |
1.3.
|
| Disclosure of employee benefits [text block] |
5.2.
|
| Disclosure of entity's operating segments [text block] |
3.1.
|
| Disclosure of events after reporting period [text block] |
NOTE 17.
|
| Disclosure of expenses by nature [text block] |
3.2.1.
|
| Disclosure of fair value of financial instruments [text block] |
9.1.8.
|
| Disclosure of finance income [text block] |
Dividendes Sanofi
|
| Disclosure of financial instruments [text block] |
Émission d’un emprunt obligataire RSE
|
| Disclosure of financial risk management [text block] |
Afin de gérer son exposition aux risques de change et de taux d’intérêt qui découle de ses opérations courantes, le Groupe utilise des instruments dérivés négociés avec des contreparties de premier plan.
|
| Disclosure of general and administrative expense [text block] |
|
| Disclosure of goodwill [text block] |
7.1.
|
| Disclosure of impairment of assets [text block] |
7.3.
|
| Disclosure of income tax [text block] |
NOTE 6.
|
| Disclosure of information about employees [text block] |
NOTE 5.
|
| Disclosure of information about key management personnel [text block] |
5.3.
|
| Disclosure of intangible assets [text block] |
7.2.
|
| Disclosure of intangible assets and goodwill [text block] |
NOTE 7.
|
| Disclosure of interests in other entities [text block] |
1.2.
|
| Disclosure of investments accounted for using equity method [text block] |
NOTE 8.
|
| Disclosure of investments other than investments accounted for using equity method [text block] |
9.3.
|
| Disclosure of issued capital [text block] |
11.1.
|
| Disclosure of liquidity risk [text block] |
10.6.
|
| Disclosure of other current assets [text block] |
3.3.3.
|
| Disclosure of other current liabilities [text block] |
3.4.
|
| Disclosure of other operating income (expense) [text block] |
NOTE 4.
|
| Disclosure of other provisions, contingent liabilities and contingent assets [text block] |
NOTE 12.
|
| Disclosure of profit (loss) from operating activities [text block] |
Résultat d’exploitation
|
| Disclosure of property, plant and equipment [text block] |
Immobilisations corporelles
|
| Disclosure of provisions [text block] |
5.4.
|
| Disclosure of research and development expense [text block] |
Frais de recherche et innovation
|
| Disclosure of reserves within equity [text block] |
11.2.
|
| Disclosure of share capital, reserves and other equity interest [text block] |
NOTE 11.
|
| Disclosure of share-based payment arrangements [text block] |
5.5.
|
| Disclosure of treasury shares [text block] |
2.3.
|